Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity.
Shin HY, Jang S, Woo HJ, Chung JH, Kim WH, Kim D, Kang M, Lim Y, Habib O, Lee J, Yang S, Lee DH, Kim MS.
Shin HY, et al. Among authors: kim wh, kim d, kim ms.
Theranostics. 2023 Mar 5;13(5):1506-1519. doi: 10.7150/thno.79942. eCollection 2023.
Theranostics. 2023.
PMID: 37056568
Free PMC article.